Logo image of CMP

COMPASS MINERALS INTERNATION (CMP) Stock Fundamental Analysis

NYSE:CMP - New York Stock Exchange, Inc. - US20451N1019 - Common Stock - Currency: USD

12.52  +0.06 (+0.48%)

After market: 12.52 0 (0%)

Fundamental Rating

2

Taking everything into account, CMP scores 2 out of 10 in our fundamental rating. CMP was compared to 152 industry peers in the Metals & Mining industry. CMP has a bad profitability rating. Also its financial health evaluation is rather negative. CMP is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CMP had negative earnings in the past year.
In the past year CMP had a positive cash flow from operations.
In multiple years CMP reported negative net income over the last 5 years.
In the past 5 years CMP always reported a positive cash flow from operatings.
CMP Yearly Net Income VS EBIT VS OCF VS FCFCMP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M

1.2 Ratios

CMP has a Return On Assets of -13.36%. This is in the lower half of the industry: CMP underperforms 70.39% of its industry peers.
CMP has a worse Return On Equity (-87.41%) than 87.50% of its industry peers.
CMP's Return On Invested Capital of 4.14% is fine compared to the rest of the industry. CMP outperforms 60.53% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CMP is significantly below the industry average of 8.57%.
The 3 year average ROIC (3.52%) for CMP is below the current ROIC(4.14%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -13.36%
ROE -87.41%
ROIC 4.14%
ROA(3y)-4.43%
ROA(5y)-1.62%
ROE(3y)-24.04%
ROE(5y)-8.91%
ROIC(3y)3.52%
ROIC(5y)3.81%
CMP Yearly ROA, ROE, ROICCMP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

CMP's Operating Margin of 5.24% is in line compared to the rest of the industry. CMP outperforms 57.24% of its industry peers.
In the last couple of years the Operating Margin of CMP has declined.
CMP has a Gross Margin (16.10%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CMP has declined.
Industry RankSector Rank
OM 5.24%
PM (TTM) N/A
GM 16.1%
OM growth 3Y-13.47%
OM growth 5Y-4.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.25%
GM growth 5Y-2.37%
CMP Yearly Profit, Operating, Gross MarginsCMP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

2

2. Health

2.1 Basic Checks

CMP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CMP has more shares outstanding than it did 1 year ago.
CMP has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CMP is higher compared to a year ago.
CMP Yearly Shares OutstandingCMP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CMP Yearly Total Debt VS Total AssetsCMP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 1.45, we must say that CMP is in the distress zone and has some risk of bankruptcy.
CMP has a Altman-Z score of 1.45. This is in the lower half of the industry: CMP underperforms 63.82% of its industry peers.
A Debt/Equity ratio of 3.67 is on the high side and indicates that CMP has dependencies on debt financing.
The Debt to Equity ratio of CMP (3.67) is worse than 90.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.67
Debt/FCF N/A
Altman-Z 1.45
ROIC/WACC0.43
WACC9.7%
CMP Yearly LT Debt VS Equity VS FCFCMP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

CMP has a Current Ratio of 2.37. This indicates that CMP is financially healthy and has no problem in meeting its short term obligations.
CMP has a Current ratio of 2.37. This is comparable to the rest of the industry: CMP outperforms 54.61% of its industry peers.
A Quick Ratio of 1.12 indicates that CMP should not have too much problems paying its short term obligations.
CMP's Quick ratio of 1.12 is on the low side compared to the rest of the industry. CMP is outperformed by 61.18% of its industry peers.
Industry RankSector Rank
Current Ratio 2.37
Quick Ratio 1.12
CMP Yearly Current Assets VS Current LiabilitesCMP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

CMP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -625.00%.
Looking at the last year, CMP shows a quite strong growth in Revenue. The Revenue has grown by 19.31% in the last year.
Measured over the past years, CMP shows a decrease in Revenue. The Revenue has been decreasing by -5.64% on average per year.
EPS 1Y (TTM)-625%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1200%
Revenue 1Y (TTM)19.31%
Revenue growth 3Y3.6%
Revenue growth 5Y-5.64%
Sales Q2Q%-10.1%

3.2 Future

Based on estimates for the next years, CMP will show a very strong growth in Earnings Per Share. The EPS will grow by 54.70% on average per year.
Based on estimates for the next years, CMP will show a small growth in Revenue. The Revenue will grow by 2.74% on average per year.
EPS Next Y-87.69%
EPS Next 2Y115.67%
EPS Next 3Y87.46%
EPS Next 5Y54.7%
Revenue Next Year3.99%
Revenue Next 2Y5.48%
Revenue Next 3Y4.96%
Revenue Next 5Y2.74%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CMP Yearly Revenue VS EstimatesCMP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
CMP Yearly EPS VS EstimatesCMP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

CMP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 19.68, which indicates a rather expensive current valuation of CMP.
Based on the Price/Forward Earnings ratio, CMP is valued a bit cheaper than 64.47% of the companies in the same industry.
CMP's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.38.
Industry RankSector Rank
PE N/A
Fwd PE 19.68
CMP Price Earnings VS Forward Price EarningsCMP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CMP indicates a somewhat cheap valuation: CMP is cheaper than 73.03% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.99
CMP Per share dataCMP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as CMP's earnings are expected to grow with 87.46% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y115.67%
EPS Next 3Y87.46%

0

5. Dividend

5.1 Amount

CMP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

COMPASS MINERALS INTERNATION

NYSE:CMP (4/25/2025, 5:05:18 PM)

After market: 12.52 0 (0%)

12.52

+0.06 (+0.48%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-10 2025-02-10/amc
Earnings (Next)05-13 2025-05-13/amc
Inst Owners81.15%
Inst Owner Change0.46%
Ins Owners0.52%
Ins Owner Change0.49%
Market Cap519.58M
Analysts77.5
Price Target15.98 (27.64%)
Short Float %6.72%
Short Ratio3.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.31
Dividend Growth(5Y)-36.2%
DP-2.7%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-267.18%
Min EPS beat(2)-463.04%
Max EPS beat(2)-71.32%
EPS beat(4)1
Avg EPS beat(4)-32.14%
Min EPS beat(4)-463.04%
Max EPS beat(4)441.38%
EPS beat(8)2
Avg EPS beat(8)27.49%
EPS beat(12)4
Avg EPS beat(12)19.16%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.19%
Min Revenue beat(2)-1.08%
Max Revenue beat(2)3.46%
Revenue beat(4)2
Avg Revenue beat(4)-1.14%
Min Revenue beat(4)-8.52%
Max Revenue beat(4)3.46%
Revenue beat(8)2
Avg Revenue beat(8)-2.06%
Revenue beat(12)5
Avg Revenue beat(12)-0.76%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-7.84%
EPS NQ rev (1m)-75%
EPS NQ rev (3m)-99.09%
EPS NY rev (1m)-3.72%
EPS NY rev (3m)-184.68%
Revenue NQ rev (1m)-0.88%
Revenue NQ rev (3m)17.26%
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)0.26%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 19.68
P/S 0.36
P/FCF N/A
P/OCF 6.85
P/B 1.98
P/tB 2.93
EV/EBITDA 7.99
EPS(TTM)-0.84
EYN/A
EPS(NY)0.64
Fwd EY5.08%
FCF(TTM)-0.6
FCFYN/A
OCF(TTM)1.83
OCFY14.61%
SpS34.33
BVpS6.34
TBVpS4.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -13.36%
ROE -87.41%
ROCE 5.24%
ROIC 4.14%
ROICexc 4.28%
ROICexgc 4.56%
OM 5.24%
PM (TTM) N/A
GM 16.1%
FCFM N/A
ROA(3y)-4.43%
ROA(5y)-1.62%
ROE(3y)-24.04%
ROE(5y)-8.91%
ROIC(3y)3.52%
ROIC(5y)3.81%
ROICexc(3y)3.61%
ROICexc(5y)3.87%
ROICexgc(3y)4%
ROICexgc(5y)4.2%
ROCE(3y)4.46%
ROCE(5y)4.82%
ROICexcg growth 3Y0.46%
ROICexcg growth 5Y-6.43%
ROICexc growth 3Y0.14%
ROICexc growth 5Y-2.76%
OM growth 3Y-13.47%
OM growth 5Y-4.55%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.25%
GM growth 5Y-2.37%
F-Score3
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 3.67
Debt/FCF N/A
Debt/EBITDA 5.34
Cap/Depr 94.73%
Cap/Sales 7.07%
Interest Coverage 1.13
Cash Conversion 41.93%
Profit Quality N/A
Current Ratio 2.37
Quick Ratio 1.12
Altman-Z 1.45
F-Score3
WACC9.7%
ROIC/WACC0.43
Cap/Depr(3y)117.41%
Cap/Depr(5y)96.99%
Cap/Sales(3y)10.32%
Cap/Sales(5y)9.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-625%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1200%
EPS Next Y-87.69%
EPS Next 2Y115.67%
EPS Next 3Y87.46%
EPS Next 5Y54.7%
Revenue 1Y (TTM)19.31%
Revenue growth 3Y3.6%
Revenue growth 5Y-5.64%
Sales Q2Q%-10.1%
Revenue Next Year3.99%
Revenue Next 2Y5.48%
Revenue Next 3Y4.96%
Revenue Next 5Y2.74%
EBIT growth 1Y5.66%
EBIT growth 3Y-10.36%
EBIT growth 5Y-9.93%
EBIT Next Year2062.02%
EBIT Next 3Y209.11%
EBIT Next 5YN/A
FCF growth 1Y-171.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44.56%
OCF growth 3Y-56.52%
OCF growth 5Y-39.81%